These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15179979)

  • 1. Pharmaceuticals and the developing world.
    Kremer M
    J Econ Perspect; 2002; 16(4):67-90. PubMed ID: 15179979
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

  • 3. Risks and benefits of importing prescription medications from lower-income countries.
    Dhalla IA; Detsky AS
    JAMA; 2008 Sep; 300(12):1453-5. PubMed ID: 18812537
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential pricing of new pharmaceuticals in lower income European countries.
    Kaló Z; Annemans L; Garrison LP
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):735-41. PubMed ID: 24219049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative factors underlying the successful investment in new ophthalmic pharmaceutical products in the United States.
    Stewart WC; Chaney PG; Stewart JA; Kruft B; Nelson LA
    Acta Ophthalmol; 2013 Sep; 91(6):e496-7. PubMed ID: 23834660
    [No Abstract]   [Full Text] [Related]  

  • 6. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
    Sykes AO
    Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299
    [No Abstract]   [Full Text] [Related]  

  • 7. The World Bank and pharmaceuticals.
    Falkenberg T; Tomson G
    Health Policy Plan; 2000 Mar; 15(1):52-8. PubMed ID: 10731235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intellectual capital as property.
    Gupta AS
    Indian J Med Ethics; 2004; 1(4):115-6. PubMed ID: 16370102
    [No Abstract]   [Full Text] [Related]  

  • 9. Economics of essential drugs schemes: the perspectives of the developing countries.
    Wang'ombe JK; Mwabu GM
    Soc Sci Med; 1987; 25(6):625-30. PubMed ID: 3686097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceuticals in U.S. health care: determinants of quantity and price.
    Berndt ER
    J Econ Perspect; 2002; 16(4):45-66. PubMed ID: 15179978
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceuticals hit the internet auction block.
    Thompson CA
    Am J Health Syst Pharm; 2000 Feb; 57(3):204. PubMed ID: 10674765
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-35. PubMed ID: 22423396
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceuticals and medical devices: business practices. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-36. PubMed ID: 23297448
    [No Abstract]   [Full Text] [Related]  

  • 14. Early benefit assessment for pharmaceuticals in Germany: lessons for policymakers.
    Schlette S; Hess R
    Issue Brief (Commonw Fund); 2013 Oct; 29():1-9. PubMed ID: 24171232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Competition and prices in the Mexican pharmaceutical market].
    Molina-Salazar RE; González-Marín E; Carbajal-de Nova C
    Salud Publica Mex; 2008; 50 Suppl 4():S496-503. PubMed ID: 19082261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mega-mergers in the pharmaceutical industry. In whose interests?
    Po AL
    Pharmacoeconomics; 1998 Oct; 14(4):349-55. PubMed ID: 10344903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hidden cost of low prices: limited access to new drugs in India.
    Berndt ER; Cockburn IM
    Health Aff (Millwood); 2014 Sep; 33(9):1567-75. PubMed ID: 25201661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the World Health Organization. Essential medicines: 25 years of better health.
    JAMA; 2002 Dec; 288(24):3102. PubMed ID: 12495381
    [No Abstract]   [Full Text] [Related]  

  • 19. The economics of essential drug programmes.
    Smith GT
    Soc Sci Med; 1987; 25(6):621-4. PubMed ID: 3686096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EU agrees deal on cheaper drugs for developing world.
    Watson R
    BMJ; 2003 Jun; 326(7401):1229. PubMed ID: 12791716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.